A randomized multicenter Phase II trial to evaluate the safety, efficacy and immunogenicity of vaccination with Folate Receptor Alpha peptides admixed with GM-CSF as a vaccine adjuvant

Administered By

Awarded By

Contributors

Start/End

  • April 2, 2018 - May 15, 2020